Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Who’s Hired? Rosemont Drives M&A With New Appointments
As EuroAPI Brings In A Chief Transformation Officer To Help Revive Its Fortunes
Jan 16 2024
•
By
David Wallace
Rosemont’s chief corporate development officer will focus on M&A • Source: Shutterstock
More from Leadership
More from Generics Bulletin